HCPCS code S9562 — Ht inj palivizumab/ab diem.
Status: Active.
Effective Apr 1, 2023.
Source: CMS HCPCS Level II.
S9562
ActiveHt inj palivizumab/ab diem
Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
Category:
Non-Medicare Temporary
Section:
S-codes: Temporary National Codes (non-Medicare)
Effective:
Apr 1, 2023
Code type:
alphanumeric
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.